TNF and cryopyrin-associated periodic syndrome: Its current FDA-approved indications are cryopyrin-associated periodic syndromes (CAPS), familial Mediterranean fever (FMF), tumor necrosis factor-alpha associated period syndrome (TRAPS), hyper-immunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MVK), adult-onset Stills disease, systemic juvenile idiopathic arthritis (JIA).